| |
 |
| |
AUDITED FINANCIAL RESULTS FOR THE QUARTER ENDED 30TH JUNE 2008
(Rs. In Lacs) |
| Particulars |
Quarter ended |
Quarter ended |
Half Year Ended |
| 30th June 2008 |
30th June 2007 |
31st Mar 2008 |
1.
|
(Gross) Sales / Income from operations |
11,162 |
7,859 |
33,585 |
| 2. |
Less : Excise Duty & Sales Tax |
991 |
798 |
2,512 |
| 3. |
(Net) Sales / Income from operations |
10,171 |
7,061 |
31,073 |
| 4. |
Other Income |
4 |
61 |
184 |
| 5. |
Total Income |
10,175 |
7,122 |
31,257 |
| 6. |
Expenditure |
|
|
|
| |
(a) |
(Increase) / Decrease in stock in trade |
161 |
(506) |
(924) |
| |
(b) |
Consumption of raw materials. |
5,962 |
4,918 |
18,259 |
| |
(c) |
Purchase of Traded Goods |
850 |
454 |
3,892 |
| |
(d) |
Employees cost |
256 |
238 |
980 |
| |
(e) |
Depreciation |
257 |
224 |
963 |
| |
(f) |
Other expenditure |
1,305 |
1,105 |
5,119 |
| 7. |
Total Expenditure |
8,719 |
6,433 |
28,289 |
| 8. |
Interest |
560 |
164 |
1,184 |
| 9. |
Exceptional Items |
- |
- |
- |
| 10. |
Profit Before Tax (PBT) |
824 |
525 |
1,783 |
| 11. |
Provision for Tax & FBT |
110 |
60 |
246 |
| 12. |
Profit After Tax (PAT) |
714 |
465 |
1,537 |
| 13. |
Provision for Deferred Tax |
63 |
57 |
230 |
| 14. |
Profit After Deferred Tax |
651 |
408 |
1,307 |
| 15. |
Paid-up Equity Share Capital of Rs.10/- each. |
1,171 |
1,171 |
1,171 |
| 16. |
Reserves & Surplus (excluding revaluation reserves) |
- |
- |
9,734 |
| 17. |
Basic E P S (in Rs.) |
5.56 |
3.48 |
11.17 |
| 18. |
Aggregate of Non Promoter Shareholding |
|
|
|
| 19. |
Number of Shares |
5932388 |
5516110 |
6045866 |
| 20. |
Percentage of Total Shareholding |
50.67 |
47.11 |
51.64 |
|
| |
| Notes : |
| 1. |
There were no pending complaints at the beginning of the Quarter. During the quarter three complaintswere received and redressed. There were no complaints pending at the end of the quarter. |
| 2. |
The above results for the Quarter ended 30-6-2008 include foreign exchange fluctuation loss of Rs.208 lakhs on account of borrowings. |
| 3. |
Company is operating as a Single Segment Company, engaged in pharmaceuticals business hence, the disclosure requirement as per AS - 17 . 'Segment Reporting' is not attracted. |
| 4. |
The figures of the previous periods have been regrouped and rearranged wherever necessary. |
| 5. |
The above results, reviewed by the Audit Committee, have been taken on record by the Board of Directors at their meeting held on 28th July, 2008. |
| For and on behalf of the Board |
| FOR AARTI DRUGS LIMITED |
| Place : Mumbai |
Harshit M Savla |
| Date : 28th July, 2008 |
(Jt. Managing Director) |
|
| |
| |
|
|
| |
| |
 |
| |
|
|
